Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1alpha in human endometrial stromal cells.

@article{Keller2000ProgesteroneEP,
  title={Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1alpha in human endometrial stromal cells.},
  author={Nancy R. Keller and Elaine Sierra-Rivera and Esther Eisenberg and Kevin G. Osteen},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2000},
  volume={85 4},
  pages={
          1611-9
        }
}
Suppression of endometrial matrix metalloproteinases (MMPs) is necessary to maintain tissue stability during the invasive events of implantation and placental development. Several laboratories have shown that inflammatory cytokines, including interleukin-lalpha (IL-1alpha), can oppose progesterone suppression of MMPs in the human endometrium. Furthermore, we have recently demonstrated colocalization of epithelial cell IL-1alpha and MMP-7 expression at sites of ectopic pregnancy. The current… 

Figures from this paper

Inhibition of matrix metalloproteinases prevents the synthesis of insulin-like growth factor binding protein-1 during decidualization in the baboon.

TLDR
It is demonstrated that IL-1beta-induced MMPs and particularly MMP-3 may up-regulate IGFBP-1 by disrupting the actin cytoskeleton as a result of ECM degradation.

Production of interleukin-1alpha by human endometrial stromal cells is triggered during menses and dysfunctional bleeding and is induced in culture by epithelial interleukin-1alpha released upon ovarian steroids withdrawal.

TLDR
The authors' experiments in cultured endometrium suggest that IL-1alpha released by epithelial cells triggers the production of IL- 1alpha by stromal cells in a paracrine amplification loop to induce MMP-1 expression during menstruation and dysfunctional bleeding.

Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice.

TLDR
In vitro treatments with retinoic acid and TGF beta restored the ability of progesterone to suppress MMPs in vitro and prevented the establishment of experimental disease.

Interleukin 1alpha and tissue-lytic matrix metalloproteinase-1 are elevated in ectopic endometrium of patients with endometriosis.

TLDR
The increased expression of both matrix-degrading MMP-1 and its major stimulatory cytokine IL-1alpha in endometriotic lesions and the selective co-expression in the stroma of endometRIotic foci clearly suggests their involvement in the pathogenic mechanisms leading to local invasion and tissue destruction.

Expression of matrix metalloproteinase-3 in mouse endometrial stromal cells during early pregnancy: Regulation by interleukin-1α and tenascin-C

TLDR
This study shows that MMP-3 expression is upregulated in endometrial stromal cells of the peri-implantation period and may be controlled by IL-1α and TN-C.

Down-regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget.

TLDR
Given the positive preclinical pharmacological profile of TNPR that has recently been reported, additional development of this compound for the treatment of endometriosis is warranted.

Regulated expression of matrix metalloproteinases, inflammatory mediators, and endometrial matrix remodeling by 17beta-estradiol in the immature rat uterus

TLDR
It is demonstrated that E2-regulated endometrial remodeling is rapid in onset (<1 hour) and peak expression of MMPs and inflammatory mediators correlates temporally with the period of lowest stromal collagen density during uterine tissue hypertrophy.

Circulating Ovarian Steroids and Endometrial Matrix Metalloproteinases (MMPs)

TLDR
The focal heterogeneity points to additional local controls of the expression and activation of MMPs in human endometrium, acting beyond the general inhibitory role of progesterone, for example, by cytokines.
...

References

SHOWING 1-10 OF 78 REFERENCES

Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1alpha and its dual block by ovarian steroids.

TLDR
It is concluded that epithelium-derived IL-1alpha is the key paracrine inducer of MMP-1 in endometrial fibroblasts, however, M MP-1 production in the human endometrium is ultimately blocked by ovarian steroids, which exerting an effective control via a "double-block" mechanism.

Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation.

TLDR
Human endometrial stromal cell cultures were established to mimic the events of the late luteal phase of the menstrual cycle, and withdrawal of P alters the ratio of MMPs to TIMPs in this model in favor of M MPs and, hence, of tissue degradation.

Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium.

TLDR
It is demonstrated that transforming growth factor beta (TGF-beta) is produced by endometrial stroma in response to progesterone and can suppress expression of epithelial matrilysin independent of progestersone, implicating TGF- beta as the principal mediator of matri Elysin suppression in the human endometrium.

Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha.

TLDR
Primary cultures of human endometrial stromal cells secreted a number of MMPs, and Northern analysis demonstrated specific messenger ribonucleic acid for pro-MMP-1 and pro- MMP-3 in phorbol myristate acetate-stimulated stroma cells.

Paracrine Regulation of Matrix Metalloproteinase Expression in the Normal Human Endometrium

TLDR
The laboratory has investigated the complex interactions between progesterone and locally produced cytokines that may affect MMP expression during the development of endometriosis and results indicate that targeting the regulation of MMPs may represent an appropriate therapeutic strategy for the treatment of endometricriosis.

Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro.

TLDR
The results showed that release of IL-1 beta parallels the invasive potential of the cytotrophoblasts; the highest levels are produced by first trimester cells and the lowest levels by term cells.

Interleukin-1 inhibits in vitro decidualization of human endometrial stromal cells.

TLDR
It is demonstrated for the first time the possibility that IL-1 blocks decidualization, the functional differentiation of human endometrial stromal cells in response to ovarian steroids.

Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression.

TLDR
Extrapolation of in vitro observations to endometrial events following RU 486 administration suggests that coordinate enhancement of MMP-3 and plasminogen activator expression promotes proteolysis of the stromal/decidual ECM, which leads toendometrial sloughing.

Localization of interleukin-1 type I receptor and interleukin-1 beta in human endometrium throughout the menstrual cycle.

TLDR
It is determined that IL-1 receptor type I (IL-1R tI) is expressed at the messenger RNA and protein levels in glandular cells and its ligand, IL- 1 beta has been localized by immunohistochemical methods in endothelial cells and isolated stromal cells in the human endometrium throughout the menstrual cycle.

Mast cell regulation of human endometrial matrix metalloproteinases: A mechanism underlying menstruation.

TLDR
Activated mast cells within the endometrium prior to menstruation have the potential to stimulate MMP production by endometrial stromal cells and to initiate precursor activation, and are likely to account for the local nature of endometricrial MMP action resulting in foci of tissue breakdown at menstruation.
...